4.3 Article

Deleterious effects of non-branded versions of imatinib used for the treatment of patients with chronic myeloid leukemia in chronic phase: a case series on an escalating issue impacting patient safety

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

The FDA's Generic-Drug Approval Process: Similarities to and Differences From Brand-Name Drugs

Costas H. Kefalas et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)